Relationships between typical histopathological hallmarks and the ferritin in the hippocampus from patients with Alzheimer’s disease

Acta Neurobiologiae Experimentalis

Volumn 75, Issue 4, 2015, Pages 391-398

  Kwiatek Majkusiak, Jolanta ^a   Dickson, Dennis W ^b   Tacik, Paweł ^b   Aoki, Naoya ^b   Tomasiuk, Ryszard ^c   Koziorowski, Dariusz ^a   Friedman, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MAYO GRADUATE SCHOOL   (United States)

^c Brodno Voivodship Hospital   (Poland)

Author keywords

Alzheimer s disease; H and L chains of ferritin; Hippocampus; Neuronal loss; Senile plaques

Indexed keywords

FERRITIN; IRON;

AGED; ALZHEIMER DISEASE; FEMALE; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; MALE; METABOLISM; MICROGLIA; MIDDLE AGED; NERVE CELL; OXIDATIVE STRESS; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; FERRITINS; HIPPOCAMPUS; HOMEOSTASIS; HUMANS; IRON; MALE; MICROGLIA; MIDDLE AGED; NEURONS; OXIDATIVE STRESS;

EID: 84955268624     PISSN: 00651400     EISSN: 16890035     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Arosio P, Cozzi A, Levi S, Luzzago A, Ruggeri G, Iacobello C, Santambrogio P, Albertini A (1990) A mutantional analysis of the epitops of recombinant human H-ferritin, Biochim. Biophys Acta 1039: 197-203.
2. Castellani RJ, Moreira PI, Perry G, Zhu X (2012) The role of iron as a mediator of oxidative stress in Alzheimer disease. Biofactors 38: 133-138.
3. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P (1995) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer’s diseased brains. J Neurochem 65: 717-724.
4. Cullen KM (1997) Perivascular astrocytes within Alzheimer’s disease plaques. Neuroreport 8: 1961-1966.
5. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28: 350-354.
6. Duvernoy H (1988) The human hippocampus: an atlas of applied anatomy (1th ed.) J.F. Bergmann-Verlag, Munich, Germany
7. Exley C, House E, Polwart A, Esiri MM (2012) Brain bur- dens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains. J Alzheimers Dis 31: 725-730.
8. Gałązka-Friedman J, Bauminger ER, Szlachta K, Koziorowski D, Tomasiuk R, Jaklewicz A, Wszołek ZK, Dickson D, Kaplińska K, Friedman A (2011) Iron in Alzheimer’s and Control Hippocampi-Mösssbauer, Atomic Absorption and ELISA Studies. Acta Phys Pol A 119: 81-83.
9. Halliwell B, Gutteridge JMC (2007) Free Radicals in Biology and Medicine (4th ed.) Oxford University Press, Oxford, UK.
10. Koziorowski D, Friedman A, Arosio P, Santambrogio P, Dziewulska D (2007) ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson’s dis- ease and incidental Lewy body compared to control. Parkinsonism Relat Disord 13: 214-218.
11. Li L, Holscher C, Chen BB, Zhang ZF, Liu YZ (2011) Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus. Biol Trace Elem Res 143: 1581-1593.
12. Luzzago A, Arosio P, Iacobello, C, Ruggeri G, Capucci L, Brocchi E, De Simone F, Gamba D, Gabri E, Levi S, Albertini A (1986) Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. Biochim Biophys Acta 872: 61-71.
13. Martins RN, Harper CG, Stokes GB, Masters CL (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer’s disease may reflect oxidative stress. J Neurochem 46: 1042-1045.
14. McGeer EG, McGeer PL (1998) The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 33: 371-378.
15. Pohanka M (2013) Alzheimer´s disease and oxidative stress: a review. Curr Med Chem 21: 356-364.
16. Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflam- matory process in Alzheimer’s disease, role of cytokines. ScientificWorldJournal 2012: 756-357.
17. Santambrogio P, Levi S, Cozzi A, Rovida E, Albertini A, Arosio P (1993) Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem 268: 12744-12748.
18. Schilling T, Eder C (2011) Amyloid-β-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia. J Cell Physiol 226: 3295-3302.
19. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer’s. Nature 382: 120-121.
20. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R (1987) Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46: 262-268.
21. Thorpe SJ, Walker D, Arosio P, Heath A, Cook J, Worwood M (1997) International collaborative study to evaluate a recombinant L ferritin preparation as an International Standard. Clin Chem 43: 1582-1587.
22. Wypijewska A, Galazka-Friedman J, Bauminger ER, Wszolek ZK, Schweitzer KJ, Dickson DW, Jaklewicz A, Elbaum D, Friedman A (2010) Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism Relat Disord 16: 329-333.
23. Vlad SC, Miller DR, Kowall NW, Felson DT (2008) Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70: 1672-1677
24. Zheng L, Rober K, Jerhammar F, Marcusson J, Terman A (2006) Oxidative stress induces intralysosomal accumu- lation of Alzheimer amyloid beta-protein in cultured neuroblastoma cells. Ann N Y Acad Sci 1067: 248-251.